Caspase-1 recognizes extended cleavage sites in its natural substrates

Related Experiment Video

Updated: Jun 17, 2026

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
05:56

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches

Published on: October 13, 2022

Jerry Shen1, Ying Yin, Jietang Mai

  • 1Department of Pharmacology, Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA 19140, United States.

Atherosclerosis
|January 12, 2010
PubMed
Abstract

Insights

Caspase-1 and caspase-9 cleavage sites differ structurally, despite sharing a P1 aspartic acid. These novel patterns aid in predicting caspase-1 substrates, crucial for inflammation and vascular disease research.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • Caspase-1 and caspase-9 are key proteases involved in distinct cellular processes like pyroptosis and apoptosis.
  • Previous assumptions suggested similar substrate preferences, failing to explain their functional divergence.

Purpose of the Study:

  • To investigate the structural differences in cleavage sites between caspase-1 and caspase-9 substrates.
  • To identify novel substrate patterns for caspase-1 to improve understanding of its roles.

Main Methods:

  • Analysis of flanking amino acid residues (20 aa) around experimentally identified cleavage sites.
  • Comparison of substrate structures for 34 caspase-1 and 11 caspase-9 substrates.

Main Results:

  • Confirmed 100% aspartic acid at the P1 position for both caspases.
  • Identified significant structural differences in cleavage sites between caspase-1 and caspase-9 substrates based on amino acid frequencies (residues, hydrophobic, charged).
  • Established distinct P1-P1' amino acid pairs and validated cleavage site patterns for 91.4% accuracy in predicting new caspase-1 substrates.

Conclusions:

  • Novel structural patterns of caspase substrates are identified.
  • These patterns are significant for developing new diagnostics and therapeutics, particularly for caspase-1 substrates involved in vascular function, inflammation, and atherogenesis.

More Related Videos

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection08:16

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection

Published on: July 21, 2022

In Vitro Cleavage Assays using Purified Recombinant Drosophila Caspases for Substrate Screening08:16

In Vitro Cleavage Assays using Purified Recombinant Drosophila Caspases for Substrate Screening

Published on: October 6, 2022

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...